Supported by NORAD and the Bill & Melinda Gates Foundation, the Lancet Commission on Investing in Health will serve as a 20-year anniversary research and consultative project to reflect on the importance today and for the future of the key findings of the World Bank's World Development Report '93. The ultimate emphasis of the CIH will be to draw lessons from past success to inform current and future policies for addressing remaining global health problems.
Increased use of accurate rapid diagnostics tests (RDTs) has the potential to better target treatment as well as cut down on drug wastage. How can use of febrile illness RDTs be expanded in the developing world, and how can we measure the costs and benefits of doing so?
Pneumococcal diseases are responsible for an estimated 826,000 deaths of children under the age of five each year. PneuMOD models interventions to reduce the burden of pneumococcal infections worldwide.
The Affordable Medicines Facility – malaria (AMFm) is an innovative financing mechanism designed to expand access to the most effective treatment for malaria, artemisinin-based combination therapies (ACTs) through the public, private and NGO sectors.
In collaboration with the University of Washington, The Center for Global Health Research, and the Public Health Foundation of India, the Disease Control Priorities Network (DCPN) aims to improve the efficacy of health resource spending in various contexts around the globe.
The Malaria Atlas Project - Elimination (MAPe) is an international scientific collaboration with
close ties to the Malaria Atlas Project (MAP). The primary mission of MAPe is to develop a
strategic planning tool for malaria elimination. The strategic planning tool is being developed to
support country-level and international planning for malaria control and elimination using a linked
set of mathematical models and supporting databases.